Drug intelligence / Profile preview

iCELL-Autism

Development stage
Preclinical
Lead developer
iCELL Biotechnology
Modality
Stem Cell Therapies → Cell Therapies
01

Overview

iCELL-Autism is an investigational cell therapy developed by iCELL Biotechnology for the treatment of Autism Spectrum Disorder (ASD). The therapy utilizes Human Amniotic Epithelial Stem Cells (hAESCs), which are pluripotent-like cells derived from the inner lining of the human placenta. These cells are characterized by their low immunogenicity, lack of telomerase (which reduces the risk of tumorigenicity), and their ability to secrete a wide range of bioactive factors, including neurotrophic factors and anti-inflammatory cytokines. In the context of autism, iCELL-Autism is intended to modulate the immune system and reduce neuroinflammation, which are hypothesized to be key contributors to the pathophysiology of the disorder. The drug is currently in the preclinical stage of development.

Other names
Human Amniotic Epithelial Stem CellshAESC

Beyond the preview

Go deeper on iCELL-Autism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iCELL-Autism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call